期刊文献+

mdr-1基因骨髓造血干细胞移植诱导大鼠肝移植免疫耐受 被引量:1

Induction of immune tolerance of rat liver transplantation via transplantation of mdr-1 gene bone marrow stem cells
下载PDF
导出
摘要 目的探讨mdr-1基因骨髓造血干细胞移植诱导肝移植术后免疫耐受的可行性及其可能机制。方法选用雄性Wistar大鼠30只为肝移植供体,另选雌性SD大鼠20只为异基因肝移植受体,随机分为mdr-1基因骨髓造血干细胞移植联合肝移植组(A组)和单纯肝移植组(B组)。雌性Wistar大鼠10只为同基因肝移植受体(C组)。比较A、B两组大鼠肝移植术后1周生存率、生存状况、生存时间,以及移植肝脏的病理变化。结果 C组大鼠生存时间均达60 d以上,A组为(31.2±4.9)d,明显高于B组[(12.1±4.7)d],差异有统计学意义(P<0.05)。B组病理组织切片可见中、重度急性排斥反应,肝内单核细胞浸润较为明显,主要集中在汇管区;A组移植肝内组织损伤程度明显减轻;C组基本无排斥反应,接近正常肝组织。结论 mdr-1基因骨髓造血干细胞可明显减轻大鼠肝移植后免疫排斥反应。 Objective To discuss the feasibility and possible mechanism of mdr-1 gene bone marrow stem cell transplantation inducing immune tolerance after liver transplantation. Methods Thirty male Wistar rats were used as the liver transplantation donors and 20 female SD rats as allogeneic liver transplantation recipients. The rats were randomly divided into two groups, ie, Group A (treated with mdr-1 gene Hematopoietic stem cell transplantation plus liver transplantation) and Group B (sole liver transplanta- tion). Ten female Wistar rats were use as syngeneic liver transplantation recipients(Group C). The survival rate, survival status, survival time and the pathological changes of the transplanted liver at one week after transplantation were compared between groups. Results The rats in Group C survived for over 60 days. The rats in Group A survived for(31.2±4.9) days,which was significantly higher than (12.1 ± 4.7) days in Group B(P〈0.05). Histologic results showed moderate to severe acute rejection, obvious intrahepatic inflammatory cell infiltration mainly in the portal area in Group B. Ttissue injury of the transplanted liver was significantly alleviated in Group A. There was little rejection in Group C,which was close to the normal liver tissue. Conclusion The results of the study indicate that transplantation of mdr-1 gene bone marrow stem cells can markedly alleviate the immunological rejection after rat liver transplantation.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第11期1046-1048,1036,共3页 Chongqing medicine
基金 贵州省省长基金资助项目[黔省专合字(2008)103] 贵州省特助基金资助项目(TZJF-2007-46) 贵州省科技厅级基金资助项目(2007-2230)
关键词 肝移植 免疫耐受 MDR-1基因 liver transplantation immune tolerance mdr- 1 gene
  • 相关文献

参考文献18

  • 1Kwekkeboom J, Tha-In T, Tra WM, et al. Hepatitis B immunoglobulins inhibit dendritritic cells and T cells and protect against acute rejection after liver transplantation[J]. Am J Transplant, 2005,21 (5) : 2393-2402.
  • 2Daly AK, Day CP, Donaldson PT. Polymorphisms immunoregulatory genes: towards individualized immunosup- pressive therapy? [J]. Am Pharmacogenomics, 2002: 2 (1):1-3.
  • 3Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for fas ligand in lung and colon cancer[J]. Nature, 1998,396(6):699-703.
  • 4Amold B. Levels of peripheral tcell tolerance[J]. Transpl Im- munol, 2002,10 (2) : 109-114.
  • 5Goddard S, Adams DH. New approaches to immunosup- pression in liver transplantation[J]. J Gastroenterol Hep- atol, 2002,17(2) : 116-126.
  • 6Kamada N,Calne RY. A surgical experience with five hun- dred thirty liver transplantation in the rat[J].Surgery, 1983, 93(1) :64-69.
  • 7Sayegh MH, Fine NA, Smith JL, et al. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors[J].Ann Intern Med, 1991,114(8) : 954-955.
  • 8Helg C, ChaDuis B, Bolle JF, et al. Renal transplantation without immunosuppression in a host with tolerance in- duced by allogeneic bone marrow transplantation [J]. Transplantation, 1994,58(11) :1420-1422.
  • 9Delriviere L, Gibbs P, Kobayashi E, et al. Detailed modifled technique for safer harvesting and preparation of liver graft in the rat[J]. Mierosurgery, 1996,17(6) : 690-699.
  • 10Metzler B, Gfeller P, Bigand M, et al. Combinations of anti- LFA-1, everolimus, anti-Cl)40 tigand, and allogeneic bone marrow induce central transplantation tolerance throughhemopoietic chimetism,including protection from Chronic heart allograft rejection [J]. J Immunol, 2004,173 ( 10 ) :702-703.

二级参考文献37

  • 1陈规划,陆敏强,蔡常洁,杨扬,何晓顺,朱晓峰.肝癌肝移植术后个体化化疗疗效初步分析[J].中华外科杂志,2004,42(17):1040-1043. 被引量:18
  • 2刘炳仁,杨纯正,栾凤君,熊冬生,刘瑞林,卞寿庚,薛艳萍,郝玉书.用逆转录-多聚酶链反应检测白血病患者多药耐药基因的表达[J].中华血液学杂志,1995,16(2):65-68. 被引量:27
  • 3曾蒙苏,张宏伟,周康荣,陆宏祺,严惠芳.供影像学诊断实验的大鼠移植肝癌模型的可行性研究[J].临床放射学杂志,1996,15(1):56-59. 被引量:14
  • 4Kienle P,Weitz J,Klaes R,et al.Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.Arch Surg,2000,135:213.
  • 5Hemming AW,Cattral MS,Reed AI,et al.Liver transplantation for hepatocellular carcinoma.Ann Surg,2001,233:652-659.
  • 6Salizzoni M,Romagnoli R,Lupo F,et al.Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.Transplantation,2003,76:844-848.
  • 7Freise CE,Ferrell L,Liu T,et al.Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.Transplantation,1999,67:510-513.
  • 8Schlitt HJ,Neipp M,Weimann A,et al.Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.J Clin Oncol,1999,17:324-331.
  • 9Castroagudin JF,Gonzalez-Quintela A,Martinez J,et al.Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation.Hepatogastroenterology,2002,49:249-251.
  • 10Roayaie S,Frischer JS,Emre SH,et al.Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters .Ann Surg,2002,235:533-539.

共引文献29

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部